Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23804235)

1.

Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications.

Wang L, Jiang R, Sun XL.

Med Res Rev. 2014 May;34(3):479-502. doi: 10.1002/med.21294. Epub 2013 Jun 26. Review.

PMID:
23804235
2.

The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen.

Kuo CH, Chen PK, Chang BI, Sung MC, Shi CS, Lee JS, Chang CF, Shi GY, Wu HL.

Blood. 2012 Feb 2;119(5):1302-13. doi: 10.1182/blood-2011-08-376038. Epub 2011 Nov 18.

3.

The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.

Van de Wouwer M, Plaisance S, De Vriese A, Waelkens E, Collen D, Persson J, Daha MR, Conway EM.

J Thromb Haemost. 2006 Aug;4(8):1813-24.

PMID:
16879225
4.

Evidence of human thrombomodulin domain as a novel angiogenic factor.

Shi CS, Shi GY, Chang YS, Han HS, Kuo CH, Liu C, Huang HC, Chang YJ, Chen PS, Wu HL.

Circulation. 2005 Apr 5;111(13):1627-36. Epub 2005 Mar 28.

5.

The role of thrombomodulin lectin-like domain in inflammation.

Li YH, Kuo CH, Shi GY, Wu HL.

J Biomed Sci. 2012 Mar 27;19:34. doi: 10.1186/1423-0127-19-34. Review.

6.

The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function.

Honda G, Masaki C, Zushi M, Tsuruta K, Sata M.

J Biochem. 1995 Nov;118(5):1030-6.

7.

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation.

Van de Wouwer M, Collen D, Conway EM.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1374-83. Epub 2004 Jun 3. Review.

8.

The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells.

Hamada H, Ishii H, Sakyo K, Horie S, Nishiki K, Kazama M.

Blood. 1995 Jul 1;86(1):225-33.

9.

Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model.

Li YH, Liu SL, Shi GY, Tseng GH, Liu PY, Wu HL.

Thromb Haemost. 2006 Jan;95(1):128-33.

PMID:
16543971
10.

Thrombomodulin in the treatment of atherothrombotic diseases.

Li YH, Shi GY, Wu HL.

Front Biosci (Schol Ed). 2009 Jun 1;1:33-8. Review.

PMID:
19482680
11.

Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.

Zhang H, Weingart J, Jiang R, Peng J, Wu Q, Sun XL.

Bioconjug Chem. 2013 Apr 17;24(4):550-9. doi: 10.1021/bc300399f. Epub 2013 Mar 15.

12.

Preparation and characterization of monoclonal antibodies to thrombomodulin.

Tsuneyoshi N, Fukudome K, Higuchi K, Kimoto M.

Hybridoma (Larchmt). 2005 Aug;24(4):189-96.

PMID:
16120024
13.

Thrombomodulin: from haemostasis to inflammation and tumourigenesis.

Koutsi A, Papapanagiotou A, Papavassiliou AG.

Int J Biochem Cell Biol. 2008;40(9):1669-73. Epub 2007 Jul 18. Review.

PMID:
17709273
14.

Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation.

Ito T, Maruyama I.

J Thromb Haemost. 2011 Jul;9 Suppl 1:168-73. doi: 10.1111/j.1538-7836.2011.04319.x.

PMID:
21781252
15.

Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.

Nawa K, Ono M, Fujiwara H, Sugiyama N, Uchiyama T, Marumoto Y.

Biochim Biophys Acta. 1994 Apr 13;1205(2):162-70.

PMID:
7512385
16.

The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition.

Wang H, Vinnikov I, Shahzad K, Bock F, Ranjan S, Wolter J, Kashif M, Oh J, Bierhaus A, Nawroth P, Kirschfink M, Conway EM, Madhusudhan T, Isermann B.

Thromb Haemost. 2012 Dec;108(6):1141-53. doi: 10.1160/TH12-07-0460. Epub 2012 Sep 26.

PMID:
23014597
17.

The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis.

Conway EM, Pollefeyt S, Collen D, Steiner-Mosonyi M.

Blood. 1997 Jan 15;89(2):652-61.

19.

The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.

Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G.

J Exp Med. 2002 Sep 2;196(5):565-77.

20.

Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain.

Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, Mullins ES, Flick MJ, Queiroz KC, Shi K, Spek CA, Conway EM, Monia BP, Weiler H, Degen JL, Palumbo JS.

Blood. 2011 Sep 8;118(10):2889-95. doi: 10.1182/blood-2011-03-341222. Epub 2011 Jul 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk